News | March 15, 2022
Granules Pharmaceuticals clears USFDA audit
This is the sixth successful USFDA audit for this facility
This is the sixth successful USFDA audit for this facility
The focus is to build collaborative learning and sharing ecosystem
He has over 25 years of rich experience in marketing and business in various sectors
The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
The initial SARS-CoV-2 research program at Calibr, the drug discovery and development division of Scripps Research, was supported by funding from the Bill & Melinda Gates Foundation
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
It is only the second generic application approved by the USFDA
Subscribe To Our Newsletter & Stay Updated
